(Q45862855)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Saporin as a novel suicide gene in anticancer gene therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Zarovni N

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Soldà T

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Monaco L

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Fabbrini MS

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

29 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

165-173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

Cancer vaccines: between the idea and the reality

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Tumour vascular targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

From bench to bedside for gene-directed enzyme prodrug therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

A polymer library approach to suicide gene therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Identification of diphtheria toxin via screening as a potent cell cycle and p53-independent cytotoxin for human prostate cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Ribosome-inactivating proteins from plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

The cytotoxic activity of ribosome-inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Alpha 2-macroglobulin receptor mediates binding and cytotoxicity of plant ribosome-inactivating proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Characterization of a saporin isoform with lower ribosome-inhibiting activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Expression and characterization of a basic fibroblast growth factor-saporin fusion protein in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

A cleavable adapter to reduce nonspecific cytotoxicity of recombinant immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Construction of tumor-specific toxins using ubiquitin fusion technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Cationic compounds used in lipoplexes and polyplexes for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Transport of an external Lys-Asp-Glu-Leu (KDEL) protein from the plasma membrane to the endoplasmic reticulum: studies with cholera toxin in Vero cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Protein toxins: intracellular trafficking for targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Immunotoxins for targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Autocrine down-regulation of basic fibroblast growth factor receptors causes mitotoxin resistance in a human melanoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Transcriptionally targeted adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Telomerase-dependent gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Optimization of a synthetic beta-catenin-dependent promoter for tumor-specific cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

Expression of MHC Class II and B7-1 and B7-2 costimulatory molecules accompanies tumor rejection and reduces the metastatic potential of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

7 January 2021

DNA-nuclease activity of the single-chain ribosome-inactivating proteins dianthin 30, saporin 6 and gelonin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

7 January 2021

Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

7 January 2021

The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

7 January 2021

Cytosolic immunization allows the expression of preATF-saporin chimeric toxin in eukaryotic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

7 January 2021

Polyethylenimine (PEI).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700998

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17008932%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 December 2019

1030295430

0 references

1 reference